Estimate VLDL cholesterol from triglycerides or the full lipid panel, then compare it with non-HDL cholesterol, remnant cholesterol, and common lipid ratios.
Very low-density lipoprotein (VLDL) cholesterol represents the triglyceride-rich lipoproteins produced by the liver and later remodeled into remnant particles and LDL. Standard lipid panels usually do not measure VLDL directly, so it is estimated from triglycerides or inferred from the full panel.
This calculator shows three simple VLDL approaches (Friedewald TG/5, a triglyceride-adjusted divisor, and direct subtraction from the full panel when LDL is available), then places the result next to non-HDL cholesterol, remnant cholesterol, and the TG/HDL ratio.
The page is meant as a lipid-pattern worksheet. It can help show whether the main issue is triglyceride-rich lipoproteins, a broader atherogenic pattern, or a triglyceride level high enough to shift attention toward pancreatitis risk as well as long-term cardiovascular risk.
This calculator gives you several ways to estimate VLDL and then places that number in the broader lipid context with non-HDL cholesterol, remnant cholesterol, and the TG/HDL ratio. That makes it easier to judge whether the problem is mostly triglyceride-rich lipoproteins, a broader atherogenic pattern, or pancreatitis-level hypertriglyceridemia.
VLDL (Friedewald) = Triglycerides ÷ 5 (mg/dL). VLDL (Martin-Hopkins) = TG ÷ adjustable factor (factor varies 5.0–8.5 based on TG level). VLDL (Panel) = TC − LDL − HDL. Non-HDL-C = TC − HDL. Remnant Cholesterol = Non-HDL-C − LDL ≈ VLDL + IDL. TG/HDL ratio (insulin resistance proxy).
Result: VLDL 70 (Friedewald), 50 (adjusted divisor), 85 (panel). Non-HDL-C 215. TG/HDL 10.0.
All three estimates point to a triglyceride-rich lipid pattern. The very high TG/HDL ratio and non-HDL cholesterol both support that this is more than an isolated LDL issue.
The classic TG/5 shortcut works best in the normal triglyceride range and gets weaker as triglycerides rise. That is why the calculator offers alternative methods and lets the lipid panel be interpreted with the same assumptions that produced the VLDL estimate.
VLDL alone is not the whole risk story. Non-HDL cholesterol captures the broader pool of atherogenic particles, while TG/HDL helps show whether insulin resistance is likely part of the picture. Those combined measures are more useful than VLDL in isolation when you are deciding how aggressive to be.
Very high triglycerides shift the question from long-term cardiovascular risk to acute pancreatitis prevention. In that setting, the calculator is most valuable as a quick way to show that the lipid pattern is no longer just a mild abnormality but a problem that needs faster action.
Last updated:
This page estimates VLDL cholesterol from triglycerides with the TG/5 shortcut, a triglyceride-adjusted divisor, and—when a full panel is supplied—by subtracting LDL and HDL from total cholesterol. It also reports non-HDL cholesterol, remnant cholesterol, and common lipid ratios so triglyceride-rich lipoproteins can be reviewed in the same context as the rest of the panel.
The result is a lipid-pattern worksheet, not a diagnosis or a treatment order. Estimated VLDL becomes less dependable when triglycerides are very high, and clinical interpretation still depends on the full lipid panel, fasting status, metabolic context, and the reason the lipids were checked.
VLDL is the triglyceride-rich portion of the lipid panel. It matters mainly because it helps describe whether the abnormality is centered on triglyceride-rich lipoproteins rather than isolated LDL alone.
The TG/5 shortcut is less dependable when triglycerides are high. That is why this page also shows an adjusted-divisor approach and, when possible, a panel-derived estimate.
Non-HDL cholesterol is total cholesterol minus HDL. It keeps the broader pool of atherogenic cholesterol visible when triglycerides are elevated.
It is a rough pattern marker that can suggest triglyceride-rich dyslipidemia or insulin resistance, but it is not a diagnosis by itself.
Once triglycerides are very high, the question is no longer just long-term cardiovascular risk. Very high levels can shift attention toward pancreatitis prevention and rapid follow-up.
Remnant cholesterol is estimated here as non-HDL cholesterol minus LDL. It is a way to keep the cholesterol carried by triglyceride-rich remnants visible on the same worksheet.